BML CAPITAL MANAGEMENT, LLC

PrivateCIK: 1616824
Location

ZIONSVILLE, IN

πŸ“‹ What this filing means

BML CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 30 equity positions with a total reported market value of $149.36M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

30
Positions
$149.36M
Total AUM (reported)
39.86M
Total Shares

Allocation by class

TOTAL AUM$149.36M30 positions
COM$81.17M54.3%
0-3 MNTH TREASRY$27.19M18.2%
COM NEW$19.05M12.8%
BLOOMBERG 1-3 MO$18.36M12.3%
ADS$3.59M2.4%

Portfolio Concentration

Top 345.5%4–1035.4%11–2517.5%Rest1.5%TOP 1080.9%0%100%
Top 3$67.92M45.5%
4–10$52.94M35.4%
11–25$26.19M17.5%
Rest$2.30M1.5%

Top 3 weight

45.5%

Top 10 weight

80.9%

Voting Authority Distribution

Total shares with voting rights: 39.86M

Sole

Full voting authority

0.00

shares

% of voting shares0.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

39.86M

shares

% of voting shares100.0%

Investment Discretion (by position count)

Sole30
Shared0
Other0
Dominant voting typeNone Β· 100.0% of voting shares
Institutional Holdings30
Rows:

ISHARES TR

SOLE
0-3 MNTH TREASRY
Shares270K
TypeSH
Market value$27.19M
18.21%
Sole
0.00
Shared
0.00
None
270K

ATEA PHARMACEUTICALS INC

SOLE
COM
Shares5.54M
TypeSH
Market value$22.37M
14.98%
Sole
0.00
Shared
0.00
None
5.54M

SPDR SER TR

SOLE
BLOOMBERG 1-3 MO
Shares200K
TypeSH
Market value$18.36M
12.29%
Sole
0.00
Shared
0.00
None
200K

ADVERUM BIOTECHNOLOGIES INC

SOLE
COM NEW
Shares833.12K
TypeSH
Market value$11.78M
7.89%
Sole
0.00
Shared
0.00
None
833.12K

ACLARIS THERAPEUTICS INC

SOLE
COM
Shares9.40M
TypeSH
Market value$11.65M
7.80%
Sole
0.00
Shared
0.00
None
9.40M

CYTEIR THERAPEUTICS INC

SOLE
COM
Shares3.65M
TypeSH
Market value$11.00M
7.36%
Sole
0.00
Shared
0.00
None
3.65M

ELIEM THERAPEUTICS INC

SOLE
COM
Shares2.19M
TypeSH
Market value$6.01M
4.02%
Sole
0.00
Shared
0.00
None
2.19M

AVROBIO INC

SOLE
COM
Shares4M
TypeSH
Market value$5.12M
3.43%
Sole
0.00
Shared
0.00
None
4M

INSTIL BIO INC

SOLE
COM NEW
Shares348.74K
TypeSH
Market value$3.77M
2.52%
Sole
0.00
Shared
0.00
None
348.74K

RENEO PHARMACEUTICALS INC

SOLE
COM
Shares2.18M
TypeSH
Market value$3.62M
2.42%
Sole
0.00
Shared
0.00
None
2.18M

CONNECT BIOPHARMA HLDGS LTD

SOLE
ADS
Shares2.06M
TypeSH
Market value$3.59M
2.40%
Sole
0.00
Shared
0.00
None
2.06M

DESIGN THERAPEUTICS INC

SOLE
COM
Shares879.48K
TypeSH
Market value$3.54M
2.37%
Sole
0.00
Shared
0.00
None
879.48K

ATHIRA PHARMA INC

SOLE
COM
Shares900K
TypeSH
Market value$2.47M
1.65%
Sole
0.00
Shared
0.00
None
900K

ORAMED PHARMACEUTICALS INC

SOLE
COM NEW
Shares844.50K
TypeSH
Market value$2.47M
1.65%
Sole
0.00
Shared
0.00
None
844.50K

PMV PHARMACEUTICALS INC

SOLE
COM
Shares1.31M
TypeSH
Market value$2.22M
1.49%
Sole
0.00
Shared
0.00
None
1.31M

ASTROTECH CORP

SOLE
COM
Shares220.41K
TypeSH
Market value$1.97M
1.32%
Sole
0.00
Shared
0.00
None
220.41K

LENZ THERAPEUTICS INC

SOLE
COM
Shares63.92K
TypeSH
Market value$1.43M
0.96%
Sole
0.00
Shared
0.00
None
63.92K

KINNATE BIOPHARMA INC

SOLE
COM
Shares498.85K
TypeSH
Market value$1.33M
0.89%
Sole
0.00
Shared
0.00
None
498.85K

ARCA BIOPHARMA INC

SOLE
COM
Shares706.93K
TypeSH
Market value$1.24M
0.83%
Sole
0.00
Shared
0.00
None
706.93K

FORTE BIOSCIENCES INC

SOLE
COM
Shares1.76M
TypeSH
Market value$1.23M
0.82%
Sole
0.00
Shared
0.00
None
1.76M

MILESTONE PHARMACEUTICALS IN

SOLE
COM
Shares606.14K
TypeSH
Market value$1.08M
0.73%
Sole
0.00
Shared
0.00
None
606.14K

VERRICA PHARMACEUTICALS INC

SOLE
COM
Shares180K
TypeSH
Market value$1.07M
0.71%
Sole
0.00
Shared
0.00
None
180K

LISATA THERAPEUTICS INC

SOLE
COM
Shares284.67K
TypeSH
Market value$888.2K
0.59%
Sole
0.00
Shared
0.00
None
284.67K

ENLIVEN THERAPEUTICS INC

SOLE
COM
Shares50.10K
TypeSH
Market value$881.3K
0.59%
Sole
0.00
Shared
0.00
None
50.10K

VISTAGEN THERAPEUTICS INC

SOLE
COM
Shares150K
TypeSH
Market value$792.0K
0.53%
Sole
0.00
Shared
0.00
None
150K
Page 1 of 2
BML CAPITAL MANAGEMENT, LLC 13F Holdings β€” 30 Positions | Finecho